OpiCalc Logo

OpiCalc

--- Clinical Tools

Logo
OpiCalc
AACE Weight LossAPRI ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordMELD ScoreNAFLD FibrosisRockall Score

Clinical Evidence and Methodology

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Use

  • All patients presenting with suspected upper GI bleeding
  • Identify patients safe for outpatient management without endoscopy
  • Predict need for clinical intervention (transfusion, endoscopy, surgery)
  • Triage urgency of inpatient endoscopy

Score 0 = Safe Discharge

A GBS score of 0 identifies patients who can safely be discharged without urgent endoscopy. This applies to ~20% of upper GI bleed presentations and can reduce unnecessary admissions.

CLINICAL INSIGHT

How it Works

Key Variables

  • BUN: Elevated BUN reflects absorbed blood — the highest-impact variable
  • Haemoglobin: Differentiates by sex (male threshold higher)
  • Systolic BP: Defines haemodynamic compromise
  • Heart rate, melaena, syncope, liver disease, cardiac failure: Binary clinical factors

Score Ranges

  • Score 0: Very low risk. Outpatient management safe. Sensitivity 98.6% for identifying low-risk.
  • Score 1–3: Low risk. Consider outpatient endoscopy.
  • Score 4–7: Moderate risk. Admit. Endoscopy within 24h.
  • Score ≥ 8: High risk. Urgent endoscopy. ICU-level monitoring.
CLINICAL INSIGHT

Practical Pearls

GBS vs Rockall Score

  • GBS: Pre-endoscopy. Predicts NEED for intervention. Best for triage.
  • Rockall Score: Post-endoscopy. Predicts REBLEEDING and mortality. Complements GBS.
  • AIM65: Also pre-endoscopy. Uses albumin, INR, mental status, SBP, age > 65. Comparable performance to GBS.

PPI Therapy

IV proton pump inhibitor (omeprazole 80mg bolus, then 8mg/h infusion) before endoscopy reduces stigmata of recent haemorrhage but does NOT reduce mortality, rebleeding, or need for surgery in most trials. Start in all admitted patients.

CLINICAL INSIGHT

Next Steps

Management by Score

  • GBS 0: Discharge. Oral PPI. Outpatient GI follow-up within 72h.
  • GBS 1–3: Consider admission for observation vs outpatient endoscopy based on clinical context.
  • GBS 4–7: Admit. Cross-match 2–4 units PRBCs. IV PPI infusion. Endoscopy within 24h.
  • GBS ≥ 8: Resuscitate. Target Hb 70–80 g/L. Urgent endoscopy (< 12h if haemodynamically unstable). GI/surgery consult.

Complementary Tools

CLINICAL INSIGHT

Evidence Base

Original Study

A risk score to predict need for treatment for upper-gastrointestinal haemorrhage.

Blatchford O, Murray WR, Blatchford M.Lancet.2000
CLINICAL INSIGHT

Background

Development at Glasgow Royal Infirmary

Developed by Blatchford, Murray, and Blatchford at Glasgow Royal Infirmary in 2000 as a pre-endoscopy triage tool to safely identify patients who did not require urgent hospitalization. Its inclusion of purely clinical and biochemical variables (no endoscopic findings required) allows application at the point of first assessment in any setting.

MELD / MELD-Na

MELD / MELD-Na (Model for End-Stage Liver Disease): Predicting 3-month mortality in patients with cirrhosis. Current UNOS standard for transplant priority.
mg/dL
mg/dL
mEq/L
No clinical reference data available.